In a group of health-related headlines, one says "Hope for new drug approach. As government-supported research in the US is being decimated by funding cuts, it was refreshing to attend iDR25 (the ...

AI is transforming drug discovery faster than deal structures can adapt. Traditional licensing frameworks were built for linear innovation: ...

Drug repurposing identifies new uses for existing medicines, including approved drugs as well as investigational drugs that have demonstrated favourable pharmaceutical properties and human safety.

Old drugs, new ideas. That’s one of the core drivers of using artificial intelligence (AI) for drug development. Researchers using complex AI-fueled methods are now taking aim at what has become a ...

Every Cure is using AI to seek new uses for the roughly 4,000 existing drugs, and cutting traditional preliminary research timelines from as much as 100 days to as little as 17 hours. Treatment for a ...

Officials from nonprofit organizations, along with a former high-ranking US Food and Drug Administration (FDA) official, are considering mechanism to encouraging nonprofits to repurpose existing ...

The FDA is looking to get thrifty with its approved drugs. Through a newly proposed repurposing initiative, the agency hopes to help address unmet medical needs by finding new uses for ...

The US Food and Drug Administration (FDA) is asking for input on repurposing older drugs for new therapeutic uses to address unmet medical needs across a wide range of therapeutic areas. FDA said that ...

A formal FDA call for repurposing nominations prioritizes areas where unmet need is high and manufacturer incentives to pursue supplemental approvals are limited. Submissions may be grounded in ...